News

Further certification attained against Clostridium Difficile from Campden BRI

Monday, August 29th, 2011

With new figures showing worrying increases in C difficile associated deaths in hospitals, Cleanitise with it’s 99.999% effective germkill can make a difference in the healthcare market.

We requested that Campden Technology Limited (Campden BRI) assess the  efficacy of Cleanitise for sporicidal activity against C. difficile using the method BSEN 13704:2002 and were delighted to receive their report:

EN 13704:2002, Chemical disinfectants – Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas. To assess the efficacy of Cleanitise for sporicidal activity against Clostridium Difficile
Download Report MB:REP:123672:1

A further 21 certificates of analysis for Cleanitise can be viewed here.

Cleanitise proven to combat E. coli

Saturday, June 11th, 2011

German tests link bean sprouts to deadly E. coli

New data released in Germany strongly suggests that locally produced bean sprouts were, as suspected, the source of the deadly E. coli outbreak. Officials initially blamed the E. coli, which has killed 29 people, on imported cucumbers, then bean sprouts. Some 3,000 people have been taken ill with the German outbreak of E. coli, which involves a previously unknown strain of the bacterium. Sufferers may develop haemolytic uraemic syndrome (HUS) where bacteria attack the kidneys and nervous system, giving them fits and often forcing them on to dialysis. (BBC News 10 June 2011)

Whether or not they are responsible for the current E. coil outbreak in Germany, sprouted seeds, unlike other fresh produce, present an unusual safety problem. Bacteria such as Salmonella and E. coil 0157:1-17 can, if present, multiply during germination and sprouting so that the sprouted seeds become a vehicle for transmission of these pathogens, especially if consumed uncooked with meals such as salads.

Published back in 2004, but still relevant today, Review of the microbiological risks associated with sprouted seeds (Review 41) pulls together information from the scientific literature on the microbiological risks associated with sprouted seeds, including potential sources of contamination during seed production, sprouting, harvesting, packing, storage and distribution. Visit www.campden.co.uk to order a copy or for more details.

Following strict tests carried out by Abbott Analytical, an independent laboratory and consulting scientists to the disinfectant industry, Cleanitise has been awarded further accreditiation to combat Escherichia coli (E. coli).

Download Certificate of Analysis No. CLE11E040Eo.

For further information on Cleanitse, please email: enquiries@cleanitise.com

 

Critically Clean – G4S use Cleanitise

Friday, May 27th, 2011

G4S is one of the largest private sector operators of ambulances in the UK, ensuring that patients are moved day and night as comfortably and securely as possible. The division covering Surrey – based in Dorking – has recently started using Cleanitise technology to ensure all vehicles are clean and free of contamination at all times. Neil Nixon, editor of Cleaning and Maintenance discovered that the results so far have been amazing.

G4S has established an expertise with people, transportation and vehicle design enabling it to provide safe, comfortable and punctual ‘round the clock’ transport services for patients of all mobility levels.

Its primary objectives are to deliver a professional patient experience and high quality care, offering a service that exceeds expectations. (more…)

Hospital virus claimed the lives of 300 in Wales last year alone

Wednesday, March 30th, 2011

A HOSPITAL superbug has claimed the lives of 300 people in the last year, reports Liz Perkins, Health Reporter for the South Wales Evening Post.

There were 23 cases of Clostridium Difficile (C.Diff) alone last month in hospitals in Swansea and Neath Port Talbot. Of those, a total of 18 were in the 66-plus age group and a further five cases were reported in the 2-65 age group.

Meanwhile, in Hywel Dda Health Board’s hospitals in Carmarthenshire, between October 1, 2009, and September 30, 2010, there were 173 cases of C. Diff out of 21,178 hospital admissions. The rate of the superbug stood at 8.17 per 100,000 admissions. (more…)

Special Spring Discounts Available

Tuesday, February 8th, 2011

Special Discounts available for all Countries!


Cleanitise UV Blacklight


Cleanitise Foggers


Cleanitise 5 Litre Concentrate

Cleanitise are providers of the Black UV Light technology and Cleanitise cleaning solution.

  • Our unique Black light technology highlights and helps to identify cleaning issues often missed by the human eye or other UV lighting methods.
  • The Cleanitise Fogging machine works by filling a room with a fine mist of Cleanitise particles, reaching areas never touched by conventional cleaning.
  • Our unique cleaning fluid Cleanitise has an effective 99.9% germ kill.
  • Cleanitise conforms to BS EN 1040 and BS EN 1276 and is suitable for all surfaces in all environment.
  • The Cleanitise system has to be used together as the lamp confirms that protein and uncleanliness are present and that the Cleanitise solution completely removed them.

Email now for special offer

First4Care private ambulance company choose Cleanitise for ambulance cleaning

Tuesday, January 4th, 2011

First4Care is a dynamic private ambulance company providing:

  • Special Educational Needs Transport for local government schools and colleges
  • Special Adult Education Transport for Social Services
  • Patient Transfer Services for NHS Ambulance Services, Hospitals, and Private Patients
  • Event Cover – First Aiders, Technicians and Ambulances
  • Industry relevant Training (first aid, ambulance technician, NVQ Road Passenger Transport)

First4Care is an influential and well respected member of the British Ambulance Association with over 10 years experience of managing private ambulance business is a leading provider of Special Educational Needs Transport and Patient Transfer Services. Having successfully gained Ambulance Service Association Accreditation first4care operates contracts for a number of Hospitals and is a preferred partner of numerous NHS Ambulance Service Trusts. (more…)

Medicar European Private Medical Transport choose Cleanitise

Monday, December 6th, 2010

Medicar European are specialists in the transport of sick and injured patients over long distances, bespoke ambulances created to provide a quiet, comfortable and secure journey without compromise of clinical care.

Medicar European clients include most of the major medical assistance companies, the NHS & Primary Care Trusts, private and corporate companies, private individuals, VIP’s, hospitals and UK and European government agencies.

Medicar European is one of only two private ambulance companies to hold an account with Eurotunnel, allowing them to travel Flexi-plus with priority loading reducing waiting times to the minimal, aiding in the quick and comfortable repatriation of patients.

All vehicles are equipped to a high base level, then supplemented with specialist equipment depending upon the patient’s condition. Their Iveco’s ambulances are high dependency units designed to accommodate 1-2 stretchers or an incubator, up to six seated patients, two wheelchairs, and a crew of two. Power stretcher lifts and full medical facilities make these vehicles ideal for the transport of cardiac, spinal, post-operation and family units.

Medicar European has chosen Cleanitise and the Cleanitise Fogger for infection control and the cleaning and decontamination of their ambulance units. The Cleanitise ambulance cleaning and disinfection fogging system is highly effective as its fine vapour accesses all surfaces and fixtures and fitting killing all surface bacteria leaving the ambulance contaminate free.

For further information on Medicar European visit their website www.medicareuropean.co.uk

For further information on Ambulance Cleaning and how Cleanitise can help you, please contact us.

Cleanitise combats Superbug NDM1 and Legionnaire’s Disease

Tuesday, October 5th, 2010

Cleanitise has been awarded further accreditation to combat Pakistan Superbug NDM 1 and Legionnaire’s Disease following strict tests carried out by Abbott Analytical, an independent laboratory and consultants to the cleaning industry.
Pakistan Superbug NDM 1

EN 1276 Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas (phase 2, step 1). Test results for Klebsiella pneumoniae (NDM-1).
Download Certificate of Analysis No. CLE10H090ND

Legionnaire’s Disease

EN 13623 Quantitative suspension test for the evaluation of bactericidal activity against Legionella pneumophila of chemical disinfectants for aqueous systems (phase 2, step 1)
Download Certificate of Analysis No. CLE10H090Lp

Professional Hygiene Services, Bristol endorse Cleanitise

Friday, July 23rd, 2010

Bristol company, Professional Hygiene Services, the market leaders in hygiene services in the South West, recommend Cleanitise for sanitary bin disinfection and calls for an addition to the Cleanitise range.

Paul Tippins, managing Director said:

“We use a wet wipe to sanitise the inside of the lids of our sanitary bins when we service them. When we clean our sanitary bins before putting them in clients sites we use Cleanitise. Could you make an antibac cleanitise wipe that could break down dried blood and sanitise the surface? A Cleanitise wipe would be a good add-on to the range.”

Cleanitise tested for MRSA Infection Control

Thursday, June 17th, 2010

Consultant microbiologist, D C Watson BSc, CBiol, MIBiol, MIFST, ACIEHO, ARSM of Abbott Analytical – the Consulting Scientists to the Disinfectant Industry, has recently conducted tests with Cleanitise, the All Purpose Surface Cleaner, Sanitiser and Degreaser, for antimicrobial efficacy against Methicillin Resistant Staphylococcus aureus (MRSA).  After testing for MRSA infection control he said:

Cleanitise All Purpose Surface Cleaner, Sanitiser and Degreaser has been tested for antimicrobial efficacy against C (MRSA) using standard EU protocols in this laboratory. It has been found to be extremely effective when diluted to 10% volume in hard water giving a total kill after five minutes, with an initial inoculum of greater than 100 million (108) bacteria per millilitre of test suspension.
Because MRSA is a particularly difficult organism to kill with standard sanitisers it’s success as a persistent pathogen in the hospital environment is largely due to ineffective cleaning and lack of residual activity on surfaces and it’s removal requires aggressive action by these chemicals. The organism is spread not only from human to human but also to all surfaces touched by contaminated hands. Cleanitise not only has this aggressive activity on MRSA but has also been shown to have a residual effect on surfaces for several hours after application and this will help to reduce the colonisation of MRSA on surfaces and hence the spread of the organism in the hospital environment.

After the tests for MRSA infection control were completed and the positive results confirmed, it was recommended that a back-up of an EN13697 surface test using MRSA to support these finding should be conducted. These tests have now been commissioned and we are awaiting the results. It is anticipated that these test results will confirm that Cleanitise is the ideal hospital cleaning product for regular cleaning of wards, equipment etc in order to reduce the spread of MRSA and infection control.

View pdf of the Abbott Analytical, Cleanitise MRSA Infection Control results